# FDA 483 - Clinogent (Div of GVK Biosciences) - March 13, 2015

Source: https://www.globalkeysolutions.net/records/483/clinogent-div-of-gvk-biosciences/8fb53bf8-dda3-4a9a-a938-d99f40c680af

> FDA 483 for Clinogent (Div of GVK Biosciences) on March 13, 2015. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Clinogent (Div of GVK Biosciences)
- Inspection Date: 2015-03-13
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2015-03-13](https://www.globalkeysolutions.net/records/483/clinogent-div-of-gvk-biosciences/c0d31deb-c9d2-41a8-b0ca-b3b7d6501cec)

## Related Officers

- [Theressa Smith](https://www.globalkeysolutions.net/people/theressa-smith/2e7c3060-94c5-4f4f-9a85-2126618bb44c)
- [Senior Vice President](https://www.globalkeysolutions.net/people/chetan-tamhankar/b0db5814-a278-43b9-814a-a0e88fed75ed)

Company: https://www.globalkeysolutions.net/companies/clinogent-div-of-gvk-biosciences/0eef1da7-c283-4b41-a86c-f5cfbf264a26

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c